Capital Increase Approved

At the February 15, 2007 extraordinary general meeting of shareholders in aap Implantate AG, a medical technology company listed in the Prime Standard Segment on the Frankfurt Stock Exchange and specialized in biomaterials and implants for trauma and joint reconstruction, all of the resolutions proposed by the Management were approved by great majorities.

The resolution on a capital increase in kind to acquire the Dutch Fame Medical Group was passed by a 99.61% “yes” vote, and the two new Supervisory Board members, Mr. Marcel Boekhoorn and Mr. Biense Visser, were also elected, polling 99.61% and 99.88% of votes respectively.

All that is now required for the transaction to take effect is for the capital increase to be entered into the Commercial Register. When that will be is not yet clear because several shareholders raised objections. Reasons for the objections were not stated at the general meeting.